# Efficacy and Safety of Meditoxin® Injection for Cervical Dystonia in Adults With Cerebral Palsy

> **NCT01860196** · PHASE4 · COMPLETED · sponsor: **Seoul National University Hospital** · enrollment: 17 (actual)

## Conditions studied

- Adult Cerebral Palsy

## Interventions

- **DRUG:** Meditoxin
- **DRUG:** Normal saline

## Key facts

- **NCT ID:** NCT01860196
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06
- **Primary completion:** 2017-03
- **Final completion:** 2017-06
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2017-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01860196

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01860196, "Efficacy and Safety of Meditoxin® Injection for Cervical Dystonia in Adults With Cerebral Palsy". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT01860196. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*